Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Woosley

Showing results (121-130 of 201) with videos related to

Pageof 21
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1988
Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointesK A Thompson, J J Murray, I A Blair, et al.
Clinical Pharmacology and Therapeutics|June 1, 1991
Pentamidine-induced torsades de pointes: safe completion of therapy with inhaled pentamidineA J Taylor, R W Hull, P E Coyne, et al.
Journal of Clinical Psychopharmacology|December 24, 1998
Prolongation of QT interval in isolated feline hearts by antipsychotic drugsM D Drici, W X Wang, X K Liu, et al.
American Heart Journal|October 1, 1983
Amiodarone dosing: a proposal based on its pharmacokineticsL A Siddoway, C B McAllister, G R Wilkinson, et al.
Circulation|February 1, 1988
Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in manJ T Barbey, K A Thompson, D S Echt, et al.
The American Journal of Cardiology|March 1, 1988
Tocainide plus quinidine for treatment of ventricular arrhythmiasJ T Barbey, K A Thompson, D S Echt, et al.
American Heart Journal|October 1, 1981
Control of ventricular preexcitation and associated arrhythmias by encainideD M Roden, H J Duff, R K Primm, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
Antiarrhythmic effects of the quaternary propranolol analog that does not induce beta-adrenergic blockadeS B Reele, D Kornhauser, D Shand, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1981
Covalent binding of procainamide in vitro and in vivo to hepatic protein in miceR W Freeman, J P Uetrecht, R L Woosley, et al.
Journal of Cardiovascular Pharmacology|September 1, 1982
Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogsV A Starnes, R K Primm, R L Woosley, et al.
Pageof 21

Showing results (121-130 of 201) with videos related to

Sort By:
Pageof 21
Clinical Pharmacology and Therapeutics|June 1, 1988
Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointesK A Thompson, J J Murray, I A Blair, et al.
Clinical Pharmacology and Therapeutics|June 1, 1991
Pentamidine-induced torsades de pointes: safe completion of therapy with inhaled pentamidineA J Taylor, R W Hull, P E Coyne, et al.
Journal of Clinical Psychopharmacology|December 24, 1998
Prolongation of QT interval in isolated feline hearts by antipsychotic drugsM D Drici, W X Wang, X K Liu, et al.
American Heart Journal|October 1, 1983
Amiodarone dosing: a proposal based on its pharmacokineticsL A Siddoway, C B McAllister, G R Wilkinson, et al.
Circulation|February 1, 1988
Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in manJ T Barbey, K A Thompson, D S Echt, et al.
The American Journal of Cardiology|March 1, 1988
Tocainide plus quinidine for treatment of ventricular arrhythmiasJ T Barbey, K A Thompson, D S Echt, et al.
American Heart Journal|October 1, 1981
Control of ventricular preexcitation and associated arrhythmias by encainideD M Roden, H J Duff, R K Primm, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
Antiarrhythmic effects of the quaternary propranolol analog that does not induce beta-adrenergic blockadeS B Reele, D Kornhauser, D Shand, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1981
Covalent binding of procainamide in vitro and in vivo to hepatic protein in miceR W Freeman, J P Uetrecht, R L Woosley, et al.
Journal of Cardiovascular Pharmacology|September 1, 1982
Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogsV A Starnes, R K Primm, R L Woosley, et al.
Pageof 21